• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hepatitis-B, typhoid vaccines launched

Thiruvananthapuram , Oct. 31

Hindustan Latex Ltd, under the Ministry of Health and Family Welfare, has entered the area of vaccines in addition to its existing wide range of contraceptive and healthcare products.

The company, in association with the Hyderabad-based Bharat Biotech International Ltd, has launched two vaccines, HIVAC-B and TYFEX, to combat hepatitis-B and typhoid respectively. The company will market these products in India and abroad.

According to company officials, HIVAC-B, a recombinant vaccine, uses HIMAX technology.

This eliminates ultra centrifugation and the use of toxic metals, while increasing the recovery of antigenic protein to higher levels. The vaccine has been manufactured without using cesium chloride.

TYFEX is a highly purified new generation typhoid vaccine. It is virtually devoid of side effects as it contains only Vi polysaccharide, the most important bacterial cell wall component that controls the virulence of typhoid bacilli.

Besides, only a single dose of the vaccine is required compared to two doses of older generation vaccines.

The vaccines add to the long list of products by Hindustan Latex such as blood collection bags, surgical sutures, auto-disable syringes, hydrocephalus shunt, tissue expanders, needle destroyers and oral re-hydration salts, apart from a range of contraceptives.

The company has drawn up a comprehensive plan to expand the products range in core areas. It has targeted a turnover of Rs 1,000 crore by 2010.

More Stories on : New Business | Contraceptives & Protectives | Health | Kerala

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Hind Latex enters vaccines business

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line